Schwab’s SCHD ETF Is Mostly Solid, But 1 Top Holding Is Concerning

Core Viewpoint - The Schwab U.S. Dividend Equity ETF (SCHD) is a favored investment option for retirees, focusing on dividend-paying U.S. stocks with strong financial metrics and a history of consistent dividend payments [1]. Dividend Yield and Top Holdings - SCHD currently offers a yield of 3.9%, surpassing most other stocks and the S&P 500 [2]. - The top five holdings contributing to this yield include: - Merck (MRK): 4.71% yield, contributing 3.51% to ETF yield - Cisco Systems (CSCO): 4.67% yield, contributing 2.06% to ETF yield - Amgen (AMGN): 4.54% yield, contributing 3.03% to ETF yield - Bristol Myers (BMY): 4.24% yield, contributing 4.9% to ETF yield - AbbVie (ABBV): 4.22% yield, contributing 3.1% to ETF yield [2]. Dividend Safety Analysis - The dividend safety varies among the top holdings, with Merck showing a conservative payout ratio of 43% and a history of uninterrupted payments for over 26 years [4]. - Cisco's payout ratio is 63%, while Amgen's is 73% and Bristol-Myers is 85%, indicating increasing risk as the payout ratios rise [5]. - AbbVie presents the highest concern with a 501% payout ratio based on trailing earnings, but its operating cash flow of $18.8 billion in 2024 allows for a more manageable 58.6% cash flow payout ratio [6][7].